Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Undersøgelse for at vurdere effektiviteten og sikkerheden af ​​Ublituximab + Umbralisib med eller uden Bendamustine og Umbralisib alene hos patienter med tidligere behandlet non-Hodgkins lymfom (UNITY-NHL)

20. juli 2022 opdateret af: TG Therapeutics, Inc.

En fase 2b randomiseret undersøgelse for at vurdere effektiviteten og sikkerheden af ​​kombinationen af ​​Ublituximab + Umbralisib med eller uden Bendamustine og Umbralisib alene hos patienter med tidligere behandlet non-Hodgkins lymfom

Unity NHL - En fase 2b randomiseret undersøgelse til vurdering af effektiviteten og sikkerheden af ​​kombinationen af ​​Ublituximab + Umbralisib med eller uden Bendamustine og Umbralisib alene hos patienter med tidligere behandlet non-Hodgkins lymfom

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Formålet med denne undersøgelse er at evaluere effektiviteten og sikkerheden af ​​umbralisib monoterapi og umbralisib + ublituximab (U2) kombinationen ved aggressive og indolente lymfomer og også at udforske U2 regimet i kombination med bendamustin i behandlingen af ​​NHL (FL, SLL, MZL, DLBCL og MCL).

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

710

Fase

  • Fase 2
  • Fase 3

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Australien
      • Gosford, Australien, 2076
        • TG Therapeutics Investigational Trial Site
    • New South Wales
      • Gosford, New South Wales, Australien, 02250
        • TG Therapeutics Investigational Trial Site
      • Wahroonga, New South Wales, Australien, 02076
        • TG Therapeutics Investigational Trial Site
    • Queensland
      • Benowa, Queensland, Australien, 04217
        • TG Therapeutics Investigational Trial Site
      • South Brisbane, Queensland, Australien, 04101
        • TG Therapeutics Investigational Trial Site
    • South Australia
      • Adelaide, South Australia, Australien, 05000
        • TG Therapeutics Investigational Trial Site
    • Victoria
      • Heidelberg, Victoria, Australien, 03084
        • TG Therapeutics Investigational Trial Site
    • Western Australia
      • Nedlands, Western Australia, Australien, 06009
        • TG Therapeutics Investigational Trial Site
      • Netherlands, Western Australia, Australien, 06009
        • TG Therapeutics Investigational Trial Site
  • Det Forenede Kongerige
      • Cambridge, Det Forenede Kongerige, CB2-0QQ
        • TG Therapeutics Investigational Trial Site
      • Denmark Hill, Det Forenede Kongerige, SE5-9RS
        • TG Therapeutics Investigational Trial Site
      • Leeds, Det Forenede Kongerige, LS97TF
        • TG Therapeutics Investigational Trial Site
      • Liverpool, Det Forenede Kongerige, L7-8XP
        • TG Therapeutics Investigational Trial Site
      • London, Det Forenede Kongerige, SW170QT
        • TG Therapeutics Investigational Trial Site
      • London, Det Forenede Kongerige, EC1A-7BE
        • TG Therapeutics Investigational Trial Site
      • Oxford, Det Forenede Kongerige, OX37LE
        • TG Therapeutics Investigational Trial Site
      • Plymouth, Det Forenede Kongerige, PL68DH
        • TG Therapeutics Investigational Trial Site
  • Forenede Stater
    • Alabama
      • Birmingham, Alabama, Forenede Stater, 35243
        • TG Therapeutics Investigational Trial Site
      • Huntsville, Alabama, Forenede Stater, 35805
        • TG Therapeutics Investigational Trial Site
    • Arizona
      • Chandler, Arizona, Forenede Stater, 85224
        • TG Therapeutics Investigational Trial Site
      • Tucson, Arizona, Forenede Stater, 85711
        • TG Therapeutics Investigational Trial Site
      • Tucson, Arizona, Forenede Stater, 85724
        • TG Therapeutics Investigational Trial Site
    • California
      • Los Angeles, California, Forenede Stater, 90095
        • TG Therapeutics Investigational Trial Site
      • Orange, California, Forenede Stater, 92868
        • TG Therapeutics Investigational Trial Site
      • San Diego, California, Forenede Stater, 92108
        • TG Therapeutics Investigational Trial Site
      • San Diego, California, Forenede Stater, 90710
        • TG Therapeutics Investigational Trial Site
      • Whittier, California, Forenede Stater, 90603
        • TG Therapeutics Investigational Trial Site
    • Colorado
      • Aurora, Colorado, Forenede Stater, 80012
        • TG Therapeutics Investigational Trial Site
      • Denver, Colorado, Forenede Stater, 80218
        • TG Therapeutics Investigational Trial Site
      • Fort Collins, Colorado, Forenede Stater, 80528
        • TG Therapeutics Investigational Trial Site
    • Connecticut
      • Bridgeport, Connecticut, Forenede Stater, 06606
        • TG Therapeutics Investigational Trial Site
    • Delaware
      • Newark, Delaware, Forenede Stater, 19713
        • TG Therapeutics Investigational Trial Site
    • District of Columbia
      • Washington, District of Columbia, Forenede Stater, 20007
        • TG Therapeutics Investigational Trial Site
    • Florida
      • Boca Raton, Florida, Forenede Stater, 33486
        • TG Therapeutics Investigational Trial Site
      • Fort Myers, Florida, Forenede Stater, 33916
        • TG Therapeutics Investigational Trial Site
      • Gainesville, Florida, Forenede Stater, 32608
        • TG Therapeutics Investigational Trial Site
      • Jacksonville, Florida, Forenede Stater, 32224
        • TG Therapeutics Investigational Trial Site
      • Jacksonville, Florida, Forenede Stater, 32204
        • TG Therapeutics Investigational Trial Site
      • Jacksonville, Florida, Forenede Stater, 32256
        • TG Therapeutics Investigational Trial Site
      • Miami, Florida, Forenede Stater, 33176
        • TG Therapeutics Investigational Trial Site
      • Saint Petersburg, Florida, Forenede Stater, 33705
        • TG Therapeutics Investigational Trial Site
      • Tallahassee, Florida, Forenede Stater, 32308
        • TG Therapeutics Investigational Trial Site
      • Tampa, Florida, Forenede Stater, 33612
        • TG Therapeutics Investigational Trial Site
      • West Palm Beach, Florida, Forenede Stater, 33407
        • TG Therapeutics Investigational Trial Site
    • Georgia
      • Albany, Georgia, Forenede Stater, 31701
        • TG Therapeutics Investigational Trial Site
      • Macon, Georgia, Forenede Stater, 31201
        • TG Therapeutics Investigational Trial Site
      • Marietta, Georgia, Forenede Stater, 30060
        • TG Therapeutics Investigational Trial Site
    • Illinois
      • Chicago, Illinois, Forenede Stater, 60612
        • TG Therapeutics Investigational Trial Site
      • Chicago, Illinois, Forenede Stater, 60637
        • TG Therapeutics Investigational Trial Site
      • Decatur, Illinois, Forenede Stater, 62526
        • TG Therapeutics Investigational Trial Site
      • Evanston, Illinois, Forenede Stater, 60201
        • TG Therapeutics Investigational Trial Site
      • Harvey, Illinois, Forenede Stater, 60426
        • TG Therapeutics Investigational Trial Site
      • Maywood, Illinois, Forenede Stater, 60153
        • TG Therapeutics Investigational Trial Site
      • Niles, Illinois, Forenede Stater, 60714
        • TG Therapeutics Investigational Trial Site
      • Peoria, Illinois, Forenede Stater, 61615
        • TG Therapeutics Investigational Trial Site
      • Swansea, Illinois, Forenede Stater, 62226
        • TG Therapeutics Investigational Trial Site
    • Indiana
      • Fort Wayne, Indiana, Forenede Stater, 46845
        • TG Therapeutics Investigational Trial Site
      • Indianapolis, Indiana, Forenede Stater, 46237
        • TG Therapeutics Investigational Trial Site
    • Kansas
      • Westwood, Kansas, Forenede Stater, 66210
        • TG Therapeutics Investigational Trial Site
    • Kentucky
      • Louisville, Kentucky, Forenede Stater, 40207
        • TG Therapeutics Investigational Trial Site
    • Louisiana
      • Covington, Louisiana, Forenede Stater, 70433
        • TG Therapeutics Investigational Trial Site
    • Maine
      • Brewer, Maine, Forenede Stater, 04412
        • TG Therapeutics Investigational Trial Site
    • Maryland
      • Baltimore, Maryland, Forenede Stater, 21201
        • TG Therapeutics Investigational Trial Site
      • Bethesda, Maryland, Forenede Stater, 20817
        • TG Therapeutics Investigational Trial Site
      • Columbia, Maryland, Forenede Stater, 21044
        • TG Therapeutics Investigational Trial Site
      • Towson, Maryland, Forenede Stater, 21204
        • TG Therapeutics Investigational Trial Site
    • Michigan
      • Ann Arbor, Michigan, Forenede Stater, 48109
        • TG Therapeutics Investigational Trial Site
    • Minnesota
      • Duluth, Minnesota, Forenede Stater, 55805
        • TG Therapeutics Investigational Trial Site
      • Saint Louis Park, Minnesota, Forenede Stater, 55416
        • TG Therapeutics Investigational Trial Site
    • Missouri
      • Columbia, Missouri, Forenede Stater, 65212
        • TG Therapeutics Investigational Trial Site
      • Kansas City, Missouri, Forenede Stater, 64132
        • TG Therapeutics Investigational Trial Site
      • Saint Louis, Missouri, Forenede Stater, 63110
        • TG Therapeutics Investigational Trial Site
    • Montana
      • Billings, Montana, Forenede Stater, 59102
        • TG Therapeutics Investigational Trial Site
    • Nebraska
      • Lincoln, Nebraska, Forenede Stater, 68510
        • TG Therapeutics Investigational Trial Site
      • Omaha, Nebraska, Forenede Stater, 68130
        • TG Therapeutics Investigational Trial Site
    • New Hampshire
      • Lebanon, New Hampshire, Forenede Stater, 03756
        • TG Therapeutics Investigational Trial Site
    • New Jersey
      • Hackensack, New Jersey, Forenede Stater, 07601
        • TG Therapeutics Investigational Trial Site
      • Morristown, New Jersey, Forenede Stater, 07962
        • TG Therapeutics Investigational Trial Site
      • Mount Holly, New Jersey, Forenede Stater, 08060
        • TG Therapeutics Investigational Trial Site
    • New Mexico
      • Farmington, New Mexico, Forenede Stater, 87401
        • TG Therapeutics Investigational Trial Site
    • New York
      • Bronx, New York, Forenede Stater, 10467
        • TG Therapeutics Investigational Trial Site
      • Buffalo, New York, Forenede Stater, 14263
        • TG Therapeutics Investigational Trial Site
      • New York, New York, Forenede Stater, 10019
        • TG Therapeutics Investigational Trial Site
      • Syracuse, New York, Forenede Stater, 13210
        • TG Therapeutics Investigational Trial Site
    • North Carolina
      • Charlotte, North Carolina, Forenede Stater, 28201
        • TG Therapeutics Investigational Trial Site
      • Durham, North Carolina, Forenede Stater, 27705
        • TG Therapeutics Investigational Trial Site
      • Hickory, North Carolina, Forenede Stater, 28602
        • TG Therapeutics Investigational Trial Site
      • Kinston, North Carolina, Forenede Stater, 28501
        • TG Therapeutics Investigational Trial Site
      • Raleigh, North Carolina, Forenede Stater, 27607
        • TG Therapeutics Investigational Trial Site
      • Washington, North Carolina, Forenede Stater, 27889
        • TG Therapeutics Investigational Trial Site
    • Ohio
      • Canton, Ohio, Forenede Stater, 44718
        • TG Therapeutics Investigational Trial Site
      • Cincinnati, Ohio, Forenede Stater, 45220
        • TG Therapeutics Investigational Trial Site
      • Cincinnati, Ohio, Forenede Stater, 45242
        • TG Therapeutics Investigational Trial Site
      • Cleveland, Ohio, Forenede Stater, 44106
        • TG Therapeutics Investigational Trial Site
      • Columbus, Ohio, Forenede Stater, 43219
        • TG Therapeutics Investigational Trial Site
      • Toledo, Ohio, Forenede Stater, 43623
        • TG Therapeutics Investigational Trial Site
    • Oregon
      • Portland, Oregon, Forenede Stater, 97227
        • TG Therapeutics Investigational Trial Site
      • Portland, Oregon, Forenede Stater, 97213
        • TG Therapeutics Investigational Trial Site
      • Springfield, Oregon, Forenede Stater, 97477
        • TG Therapeutics Investigational Trial Site
    • Pennsylvania
      • Camp Hill, Pennsylvania, Forenede Stater, 17011
        • TG Therapeutics Investigational Trial Site
      • Philadelphia, Pennsylvania, Forenede Stater, 19106
        • TG Therapeutics Investigational Trial Site
    • Rhode Island
      • Providence, Rhode Island, Forenede Stater, 02906
        • TG Therapeutics Investigational Trial Site
    • South Carolina
      • Greenville, South Carolina, Forenede Stater, 29615
        • TG Therapeutics Investigational Trial Site
    • South Dakota
      • Sioux Falls, South Dakota, Forenede Stater, 57105
        • TG Therapeutics Investigational Trial Site
      • Watertown, South Dakota, Forenede Stater, 57201
        • TG Therapeutics Investigational Trial Site
    • Tennessee
      • Chattanooga, Tennessee, Forenede Stater, 37404
        • TG Therapeutics Investigational Trial Site
      • Kingsport, Tennessee, Forenede Stater, 37660
        • TG Therapeutics Investigational Trial Site
      • Knoxville, Tennessee, Forenede Stater, 37916
        • TG Therapeutics Investigational Trial Site
      • Memphis, Tennessee, Forenede Stater, 38120
        • TG Therapeutics Investigational Trial Site
    • Texas
      • Austin, Texas, Forenede Stater, 78705
        • TG Therapeutics Investigational Trial Site
      • Dallas, Texas, Forenede Stater, 75390
        • TG Therapeutics Investigational Trial Site
      • Fort Sam Houston, Texas, Forenede Stater, 78234
        • TG Therapeutics Investigational Trial Site
      • Houston, Texas, Forenede Stater, 77030
        • TG Therapeutics Investigational Trial Site
      • San Antonio, Texas, Forenede Stater, 78229
        • TG Therapeutics Investigational Trial Site
      • San Antonio, Texas, Forenede Stater, 78217
        • TG Therapeutics Investigational Trial Site
      • San Antonio, Texas, Forenede Stater, 78130
        • TG Therapeutics Investigational Trial Site
      • Tyler, Texas, Forenede Stater, 75702
        • TG Therapeutics Investigational Trial Site
    • Utah
      • Ogden, Utah, Forenede Stater, 84403
        • TG Therapeutics Investigational Trial Site
    • Virginia
      • Blacksburg, Virginia, Forenede Stater, 24060
        • TG Therapeutics Investigational Trial Site
      • Newport News, Virginia, Forenede Stater, 23601
        • TG Therapeutics Investigational Trial Site
    • Washington
      • Olympia, Washington, Forenede Stater, 98502
        • TG Therapeutics Investigational Trial Site
      • Seattle, Washington, Forenede Stater, 98109
        • TG Therapeutics Investigational Trial Site
      • Seattle, Washington, Forenede Stater, 98104
        • TG Therapeutics Investigational Trial Site
      • Seattle, Washington, Forenede Stater, 98108
        • TG Therapeutics Investigational Trial Site
      • Spokane, Washington, Forenede Stater, 99216
        • TG Therapeutics Investigational Trial Site
      • Vancouver, Washington, Forenede Stater, 97277
        • TG Therapeutics Investigational Trial Site
    • Wisconsin
      • Madison, Wisconsin, Forenede Stater, 53792
        • TG Therapeutics Investigational Trial Site
      • Wauwatosa, Wisconsin, Forenede Stater, 53226
        • TG Therapeutics Investigational Trial Site
  • Israel
      • Ashkelon, Israel, 7830604
        • TG Therapeutics Investigational Trial Site
      • Be'er Sheva, Israel, 8410101
        • TG Therapeutics Investigational Trial Site
      • Haifa, Israel, 91031
        • TG Therapeutics Investigational Trial Site
      • Jerusalem, Israel, 9112001
        • TG Therapeutics Investigational Trial Site
      • Nahariya, Israel, 2210001
        • TG Therapeutics Investigational Trial Site
      • Petah Tikva, Israel, 49100
        • TG Therapeutics Investigational Trial Site
      • Tel Aviv, Israel, 64239
        • TG Therapeutics Investigational Trial Site
      • Tel Aviv, Israel, 6971028
        • TG Therapeutics Investigational Trial Site
  • Italien
      • Bologna, Italien, 40138
        • TG Therapeutics Investigational Trial Site
      • Ferrara, Italien, 44020
        • TG Therapeutics Investigational Trial Site
      • Milan, Italien, 20132
        • TG Therapeutics Investigational Trial Site
      • Milan, Italien, 20141
        • TG Therapeutics Investigational Trial Site
      • Rome, Italien, 00161
        • TG Therapeutics Investigational Trial Site
      • Torino, Italien, 10126
        • TG Therapeutics Investigational Trial Site
  • Korea, Republikken
      • Busan, Korea, Republikken, 47392
        • TG Therapeutics Investigational Trial Site
      • Busan, Korea, Republikken, 49241
        • TG Therapeutics Investigational Trial Site
      • Gyeonggi-do, Korea, Republikken, 13620
        • TG Therapeutics Investigational Trial Site
      • Incheon, Korea, Republikken, 21565
        • TG Therapeutics Investigational Trial Site
      • Seoul, Korea, Republikken, 03080
        • TG Therapeutics Investigational Trial Site
      • Seoul, Korea, Republikken, 06351
        • TG Therapeutics Investigational Trial Site
      • Seoul, Korea, Republikken, 06591
        • TG Therapeutics Investigational Trial Site
  • Polen
      • Chorzów, Polen, 41-500
        • TG Therapeutics Investigational Trial Site
      • Gdynia, Polen, 81-519
        • TG Therapeutics Investigational Trial Site
      • Kraków, Polen, 30-510
        • TG Therapeutics Investigational Trial Site
      • Lublin, Polen, 20-090
        • TG Therapeutics Investigational Trial Site
      • Słupsk, Polen, 76-200
        • TG Therapeutics Investigational Trial Site
      • Warszawa, Polen, 02-781
        • TG Therapeutics Investigational Trial Site
      • Warszawa, Polen, 02-106
        • TG Therapeutics Investigational Trial Site
      • Wrocław, Polen, 50-367
        • TG Therapeutics Investigational Trial Site
      • Łódź, Polen, 93-513
        • TG Therapeutics Investigational Trial Site
  • Slovakiet
      • Bratislava, Slovakiet, 81250
        • TG Therapeutics Investigational Trial Site
      • Bratislava, Slovakiet, 83310
        • TG Therapeutics Investigational Trial Site
      • Košice, Slovakiet, 04191
        • TG Therapeutics Investigational Trial Site
      • Poprad, Slovakiet, 05801
        • TG Therapeutics Investigational Trial Site
  • Spanien
      • Barcelona, Spanien, 08035
        • TG Therapeutics Investigational Trial Site
      • Barcelona, Spanien, 08041
        • TG Therapeutics Investigational Trial Site
      • Madrid, Spanien, 28041
        • TG Therapeutics Investigational Trial Site
      • Madrid, Spanien, 28222
        • TG Therapeutics Investigational Trial Site
      • Salisbury, Spanien, 37007
        • TG Therapeutics Investigational Trial Site
      • Valencia, Spanien, 46010
        • TG Therapeutics Investigational Trial Site

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (VOKSEN, OLDER_ADULT)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inklusionskriterier:

  • Diagnose af non-Hodgkins lymfom inklusive follikulært, mantelcellelymfom og marginal zone lymfom
  • Tilbagefald eller refraktær over for tidligere standardbehandling og forsøgspersoner, der ikke er kandidater til højdosisbehandling eller autolog stamcelletransplantation
  • MCL-personer med en eller flere behandlingslinjer inklusive mindst én BTK-hæmmer (kun ibrutinib, acalabrutinib eller zanibrutinib)

Ekskluderingskriterier:

  • Enhver større operation, kemoterapi eller immunterapi inden for de sidste 21 dage
  • Tegn på hepatitis B-virus, hepatitis C-virus eller kendt HIV-infektion
  • Autolog hæmatologisk stamcelletransplantation inden for 6 måneder efter studiestart. Tidligere allogen hæmatologisk stamcelletransplantation er udelukket
  • Forudgående behandling med en PI3K delta-hæmmer

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: BEHANDLING
  • Tildeling: TILFÆLDIGT
  • Interventionel model: PARALLEL
  • Maskning: INGEN

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
EKSPERIMENTEL: Umbralisib + Ublituximab
Umbralisib oral daglig dosis i kombination med Ublituximab intravenøs administration
Biologisk: Ublituximab
Andre navne:
  • TG-1101
Medicin: Umbralisib
Andre navne:
  • TGR-1202
EKSPERIMENTEL: Umbralisib
Umbralisib oral daglig dosis
Medicin: Umbralisib
Andre navne:
  • TGR-1202
EKSPERIMENTEL: Umbralisib + Ublituximab + Bendamustine
Umbralisib oral daglig dosis i kombination med Ublituximab intravenøs administration og Bendamustine intravenøs administration
Biologisk: Ublituximab
Andre navne:
  • TG-1101
Medicin: Umbralisib
Andre navne:
  • TGR-1202
Biologisk: Bendamustine
Andre navne:
  • Treanda

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Samlet svarprocent
Tidsramme: Hver 8.-12. uge, op til 2 år
Hver 8.-12. uge, op til 2 år

Sekundære resultatmål

Resultatmål
Tidsramme
Progressionsfri overlevelse
Tidsramme: Fra dato for randomisering til dato for første dokumenterede progression, vurderet op til 2 år
Fra dato for randomisering til dato for første dokumenterede progression, vurderet op til 2 år

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

TG Therapeutics, Inc.

Efterforskere

  • Studiestol: Owen A O'Connor, MD, PhD, Columbia University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (FAKTISKE)

25. maj 2016

Primær færdiggørelse (FAKTISKE)

31. maj 2022

Studieafslutning (FAKTISKE)

4. juli 2022

Datoer for studieregistrering

Først indsendt

23. maj 2016

Først indsendt, der opfyldte QC-kriterier

3. juni 2016

Først opslået (SKØN)

8. juni 2016

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (FAKTISKE)

21. juli 2022

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. juli 2022

Sidst verificeret

1. juli 2022

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • UTX-TGR-205

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

Data vil blive delt, når det sidste patientbesøg er gennemført

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Follikulært lymfom

Kliniske forsøg med Ublituximab

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Uruguay

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner